Mumbai and Bangalore: these are the locations of the two seminars held by the ASAlaser’s staff and dedicated to doctors and physiotherapists who have been able to deepen their knowledge of MLS® Laser Therapy..
After a theoretical session, mainly focused on researches conducted on the therapy, has followed a practical session on the correct use of the protocols and their applications. «The more than twenty doctors and physiotherapists who have taken part in the Mumbai’s training day, even though it was Sunday- says Lucio Zaghetto, ASAlaser’s CEO and speaker at the training - have interacted for the entire duration of the course, participating actively and asking many questions during the theoretical part. But above all in the hands-on phase they have demonstrated their involvement: many of them have in fact directly tested the immediacy and effectiveness of our therapeutic proposal». Also the specialists present in Bangalore have been proactive. Here, in order to allow the better understanding of the treatment and its uses, have been organized two groups of study, directly involved in the use of the automatic version of M6 device and of the portable Mphi. «The result of the courses has been excellent as confirmed by the same participants. If, in fact, at the beginning of the training, some members had declared their satisfaction in the use of low-level laser, at the end of the seminar, they have realized that the MLS® Laser Therapy could open new perspectives and new applications of great value for their profession. This positive feedback - concludes Zaghetto - besides having further strengthened the enthusiasm of our local partner Biotech, is very promising for the future». Future that for ASAlaser is also oriented towards India. «The choice of Mumbai and Bangalore as locations of our seminars is not a coincidence. If in Mumbai is located our distributor - says Giacomo Granozio, ASAlaser’s Area Manager - Bangalore, internationally known as a leading hub for high technology, is also the city where has been installed the first robotic system M6 at AIM (Access Innovative Medicine). For all these reasons, we have considered appropriate, in agreement with our partners, to choose these two capitals, which are an effective access point to the country to spread the knowledge of our therapeutic solutions».
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.